The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of everolimus in advanced, progressive, nonfunctional neuroendocrine tumors (NET) of the gastrointestinal (GI) tract and unknown primary: A subgroup analysis of the phase III RADIANT-4 trial.
 
Simron Singh
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Carlo Carnaghi
No Relationships to Disclose
 
Roberto Buzzoni
Research Funding - Italfarmaco (Inst); Novartis (Inst); Otsuka (Inst)
Travel, Accommodations, Expenses - Ipsen; Italfarmaco; Novartis
 
Rodney F. Pommier
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Novartis
 
Markus Raderer
Honoraria - Celgene; Ipsen; Novartis; Roche
Consulting or Advisory Role - Celgene; Ipsen; Novartis; Roche
 
Jiri Tomasek
Honoraria - Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Harald Lahner
Honoraria - Ipsen; Novartis; Pfizer
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer
 
Juan W. Valle
Honoraria - Advanced Accelerator Applications; AstraZeneca; Celgene; Ipsen; Novartis; Sirtex Medical
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; Celgene; Ipsen; Novartis; Sirtex Medical
Speakers' Bureau - Abbott Nutrition; Celgene; Ipsen; Novartis; Pfizer; Sirtex Medical
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis
 
Maurizio Voi
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Lida Bubuteishvili-Pacaud
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jeremie Lincy
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Carolin Sachs
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Natsuko Okita
Research Funding - Novartis (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst); Teijin Pharma (Inst)
 
Steven K. Libutti
Stock and Other Ownership Interests - AAVP Biosystems
Research Funding - Oxigene (Inst)
Patents, Royalties, Other Intellectual Property - National Cancer Institute
Travel, Accommodations, Expenses - Oxigene
 
Do-Youn Oh
No Relationships to Disclose
 
Matthew H. Kulke
Consulting or Advisory Role - Ipsen; Novartis
 
Jonathan R. Strosberg
Honoraria - Novartis
Consulting or Advisory Role - Ipsen; Lexicon; Novartis
Speakers' Bureau - Bayer; Genentech
Research Funding - Novartis (Inst); Pfizer (Inst)
 
James C. Yao
Consulting or Advisory Role - Ipsen; Lexicon; Novartis
Research Funding - Novartis (Inst)
 
Marianne E. Pavel
Honoraria - Ipsen; Lexicon; Novartis; Pfizer
Consulting or Advisory Role - Ipsen; Lexicon; Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Nicola Fazio
Honoraria - Ipsen; Novartis
Consulting or Advisory Role - Ipsen; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Ipsen; Novartis